PKBO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PKBO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Peak Bio's change in inventory for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Peak Bio's inventory stayed the same from Mar. 2023 to Jun. 2023 .
Peak Bio's change in inventory for the fiscal year that ended in Dec. 2022 was $0.00 Mil. It means Peak Bio's inventory stayed the same from Dec. 2021 to Dec. 2022 .
Peak Bio's Total Inventories for the quarter that ended in Jun. 2023 was $0.00 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
The historical data trend for Peak Bio's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peak Bio Annual Data | |||||
Trend | Dec21 | Dec22 | |||
Change In Inventory | - | - |
Peak Bio Quarterly Data | ||||||||
Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Change In Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peak Bio (OTCPK:PKBO) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Peak Bio's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 0 | / | 0 | * | 365 / 4 | |
= | N/A |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Peak Bio's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0 | / | 0 | |
= | N/A |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Peak Bio's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 0 | |
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Peak Bio's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Hoyoung Huh | director | C/O NEKTAR THERAPEUTICS, 201 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Michael R. Friedman | director | 245 E. 58TH STREET, APT #15B, NEW YORK NY 10022 |
Peter David Mccabe | officer: General Counsel | 584 CASTRO STREET, #882, SAN FRANCISCO CA 94114 |
Sbi Kis 2016-1 Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO GANGNAM, SEOUL M5 00000 |
2014 Kif-sbi It Investment Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
2019 Sbi Job Creation Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Sbi Investment Korea Co., Ltd. | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Sbi Healthcare Fund I | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Sbi Cross-border Advantage Fund | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Bio Fund 1 Ikbc-sbi | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Gateway Fund 1 Global | 10 percent owner | 14TH FL., NC TOWER, 509, TEHERAN-RO, GANGNAM, SEOUL M5 00000 |
Nevan C Elam | director | C/O NEKTAR THERAPEUTICS, 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Satyajit Kumar Mitra | officer: See Remarks | 3350 W BAYSHORE ROAD, SUITE 100, PALO ALTO CA 94303 |
Stephen J Lamond | director, officer: See Remarks | 3350 W BAYSHORE ROAD, SUITE 100, PALO ALTO CA 94303 |
David I. Rosenberg | director | C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019 |
From GuruFocus
By GuruFocus Research • 09-14-2023
By Marketwired • 08-31-2023
By Marketwired • 09-19-2023
By Marketwired • 08-31-2023
By Business Wire Business Wire • 11-04-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.